title: Use of ceftriaxone in the treatment of bacterial infections in cirrhotic patients.
abstract: Sixty-two episodes of bacterial infection were studied in 51 cirrhotic patients. 2 g of ceftriaxone (active ingredient of Rocephin) were given intravenously once daily for 7-10 days. The infections were pneumonia, bacteremia, spontaneous bacterial peritonitis, urinary infection and others. Good responses were seen in 90% of the cases.
authors.affiliation: Digestive Service, Arrixaca, Murcia, Spain.
authors.forename: J
authors.initials: J
authors.lastname: Mercader
authors.forename: J
authors.initials: J
authors.lastname: Gomez
authors.forename: J
authors.initials: J
authors.lastname: Ruiz
authors.forename: M C
authors.initials: MC
authors.lastname: Garre
authors.forename: M
authors.initials: M
authors.lastname: Valdes
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001424:Bacterial Infections / Q000188:drug therapy* / Q000382:microbiology; D002443:Ceftriaxone / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008103:Liver Cirrhosis / Q000378:metabolism*; D008297:Male; D008875:Middle Aged; D010538:Peritonitis / Q000188:drug therapy*; D011014:Pneumonia; D018805:Sepsis / Q000188:drug therapy* / Q000382:microbiology; D014552:Urinary Tract Infections
chemical_list: D002443:Ceftriaxone